Characterization of SARS-CoV-2 Omicron BA.2.75 clinical isolates.
Characterization of SARS-CoV-2 Omicron BA.2.75 clinical isolates.
复制标题
DOI:
10.1038/s41467-023-37059-x
复制
发表时间:
2023-03-23
影响因子:
16.6
通讯作者:
Kawaoka, Yoshihiro
中科院分区:
文献类型:
--
作者:
Uraki, Ryuta;Iida, Shun;Halfmann, Peter J.;Yamayoshi, Seiya;Hirata, Yuichiro;Iwatsuki-Horimoto, Kiyoko;Kiso, Maki;Ito, Mutsumi;Furusawa, Yuri;Ueki, Hiroshi;Sakai-Tagawa, Yuko;Kuroda, Makoto;Maemura, Tadashi;Kim, Taksoo;Mine, Sohtaro;Iwamoto, Noriko;Li, Rong;Liu, Yanan;Larson, Deanna;Fukushi, Shuetsu;Watanabe, Shinji;Maeda, Ken;Wang, Zhongde;Ohmagari, Norio;Theiler, James;Fischer, Will;Korber, Bette;Imai, Masaki;Suzuki, Tadaki;Kawaoka, Yoshihiro
The prevalence of the Omicron subvariant BA.2.75 rapidly increased in India and Nepal during the summer of 2022, and spread globally. However, the virological features of BA.2.75 are largely unknown. Here, we evaluated the replicative ability and pathogenicity of BA.2.75 clinical isolates in Syrian hamsters. Although we found no substantial differences in weight change among hamsters infected with BA.2, BA.5, or BA.2.75, the replicative ability of BA.2.75 in the lungs is higher than that of BA.2 and BA.5. Of note, BA.2.75 causes focal viral pneumonia in hamsters, characterized by patchy inflammation interspersed in alveolar regions, which is not observed in BA.5-infected hamsters. Moreover, in competition assays, BA.2.75 replicates better than BA.5 in the lungs of hamsters. These results suggest that BA.2.75 can cause more severe respiratory disease than BA.5 and BA.2 in a hamster model and should be closely monitored. Omicron subvariants may differ in their replicative fitness and their potential to cause more severe disease. In this study, the authors characterized Omicron BA.2.75 in a hamster model and found that it replicates more efficiently in the lungs than BA.2 and BA.5.
登录
查看更多内容
DOI:
10.1038/s41577-022-00676-6
发表时间:
2022-03
期刊:
Nature reviews. Immunology
影响因子:
--
作者:
Flemming A
通讯作者:
Flemming A
影响因子:
5.4
作者:
Dagotto, Gabriel;Mercado, Noe B.;Barouch, Dan H.
通讯作者:
Barouch, Dan H.
影响因子:
64.8
作者:
Meng B;Abdullahi A;Ferreira IATM;Goonawardane N;Saito A;Kimura I;Yamasoba D;Gerber PP;Fatihi S;Rathore S;Zepeda SK;Papa G;Kemp SA;Ikeda T;Toyoda M;Tan TS;Kuramochi J;Mitsunaga S;Ueno T;Shirakawa K;Takaori-Kondo A;Brevini T;Mallery DL;Charles OJ;CITIID-NIHR BioResource COVID-19 Collaboration;Genotype to Phenotype Japan (G2P-Japan) Consortium;Ecuador-COVID19 Consortium;Bowen JE;Joshi A;Walls AC;Jackson L;Martin D;Smith KGC;Bradley J;Briggs JAG;Choi J;Madissoon E;Meyer KB;Mlcochova P;Ceron-Gutierrez L;Doffinger R;Teichmann SA;Fisher AJ;Pizzuto MS;de Marco A;Corti D;Hosmillo M;Lee JH;James LC;Thukral L;Veesler D;Sigal A;Sampaziotis F;Goodfellow IG;Matheson NJ;Sato K;Gupta RK
通讯作者:
Gupta RK
影响因子:
64.5
作者:
Korber, Bette;Fischer, Will M.;Montefiori, David C.
通讯作者:
Montefiori, David C.
DOI:
10.1016/j.ajpath.2022.01.007
发表时间:
2022-04
期刊:
The American journal of pathology
影响因子:
--
作者:
Christensen PA;Olsen RJ;Long SW;Snehal R;Davis JJ;Ojeda Saavedra M;Reppond K;Shyer MN;Cambric J;Gadd R;Thakur RM;Batajoo A;Mangham R;Pena S;Trinh T;Kinskey JC;Williams G;Olson R;Gollihar J;Musser JM
通讯作者:
Musser JM